Navigation Links
Mesa Laboratories Names New Vice President of Sales and Marketing
Date:10/1/2007

LAKEWOOD, Colo., Oct. 1 /PRNewswire-FirstCall/-- Mesa Laboratories, Inc. has named Glenn Adriance as Vice President of Sales and Marketing. Mr. Adriance brings to Mesa a proven track record of developing, implementing and managing effective sales and marketing strategies in a variety of markets.

"Glenn brings a wealth of experience to Mesa," said John Sullivan, President of Mesa Labs. "I am pleased to welcome Glenn to the Mesa team. His leadership and experience will help solidify Mesa's sales and marketing programs, driving sales growth in the years ahead."

Mr. Adriance brings nearly 25 years of sales and marketing experience to Mesa. Much of that time was spent at IBM in increasingly more responsible roles within their field sales organization. Following a successful career at IBM, Mr. Adriance joined Lakeview Technology and then Scientific Technologies Corporation (STC), both in the Denver area. In his latest position, Mr. Adriance was Chief Operating Officer at STC, involved in delivering software solutions to the healthcare industry in the U.S and international markets. Mr. Adriance holds a Bachelor's degree from The University of Massachusetts and an MBA from Colorado State University.

Mesa Laboratories develops, acquires, manufactures and markets electronic instruments and disposables for industrial, pharmaceutical and medical applications.


'/>"/>
SOURCE Mesa Laboratories, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Dr Reddy’s Laboratories to challenge patents on drug
2. Dr Reddy’s Laboratories launches Hyalosy
3. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
4. Abbott Laboratories to buy Biocompatibles cardiovascular stent business
5. Abbott’s Laboratories R&D Capabilities Questione
6. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
7. ICMR to Set up Laboratories to Combat Bird Flu
8. Ranbaxy Laboratories to Be Aided in Drug Research
9. Bangladesh to Set Up HIV/AIDS Diagnosis Laboratories
10. Vietnamese Scientists Unravel Genetic Code Of Bird Flu Virus
11. Financial Allowances Being Offered To Poor Vietnamese HIV Carriers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...N ARBOR, Mich., Nov. 9 The media...ear zero in the third quarter of 2008 to more than...g to an analysis of hospital financial performance...overy has been broad-based, with all classes of ho...tals, teaching hospitals and major teaching hospit...
(Date:11/9/2009)...USTON, Nov. 9 Natural Nutrition an...Inc., which will become a wholly owned subsidiary ...ll be changed to App Tech, Corp. and the company w...Global, Inc. ,, App Tech is developing mobile a...ries of the world. App Tech is focused on multi p...
(Date:11/9/2009)...N DIEGO, Nov. 9 Renewal Laboratori...pending process to produce functional beverages wi... Natural, nutritionally important supplements suc...l may now be offered in appealing and refreshing d...ue line of all natural drinks that can help mainta...
(Date:11/9/2009)... NANJING, China, Nov. 9 /PRNewswire-Asia/ -- Simc...or the "Company"), a leading pharmaceutical compan...and marketing of branded,generic and proprietary p...ent,to acquire the manufacturing license in China ... Co., Ltd. ("Tianda"). The acquisition of the,manu...
(Date:11/9/2009)...SHINGTON, Nov. 9 Today,...es brings us one step closer to meaningful health ...le Health Care for America Act makes health care m...icans by enhancing coverage, promoting preventive ...stone also serves as a sober reminder of the treme...
Breaking Medicine News(10 mins):Health News:Hospital Financials Have Recovered to Pre-Recession Levels, According to Thomson Reuters Study 2Health News:Hospital Financials Have Recovered to Pre-Recession Levels, According to Thomson Reuters Study 3Health News:Renewal Laboratories(TM) Announces the First Omega3 Supplement Water for Cardiac Health 2Health News:Simcere Pharmaceutical Group to Acquire China Manufacturing License for Rosuvastatin 2
...s physicians keep up to date with the latest in Ca...in the detection of cardiovascular disease. CVCTA ...ng to cardiovascular imaging. Led by Medical Direc... 2008 -- CVCTA Education of San Francisco, the l...
...atisfaction with life? Then the pen may be a might... University,s Dr. Steven Toepfer. , Toepfer, an a...at university,s Salem Campus, says that expressive...rican dream. We are wealthier than previous genera...
...TM) Campaign Reaches $1 Million Dollar Donation Go...d Banks in Need , , NEW YORK, Nov. 25 Weight...e donation of one million dollars to two hunger fi...ight Watchers Online Subscribers during Lose For G...
...rtment of Energy,s (DOE) Brookhaven National Labor...B2 for the design of a "medical synchrotron" capab...on to cancerous tumors with minimal damage to surr...lity and benefits of this treatment for cancer pat...
...o-Assisted Thoracic Surgeon Dr. Robert J. Caccaval...nce, Dedication , , SOMERSET, N.J., Nov. 25 ...ay announced that one of its leading thoracic surg...Jersey Monthly,s annual list of "Top Doctors" t...
...ional, Inc. (Amex: BUF ) today announced that it...sthetics for the human market in the United States...ned subsidiary of RxElite Inc.(OTC Bulletin Board:...n overdue accounts owed to MINRAD International, I...
Other Medicine News:Health News:CVCTA Education Expands to Six New Campuses and Finalizes Acquisition Of CVI Training 2Health News:CVCTA Education Expands to Six New Campuses and Finalizes Acquisition Of CVI Training 3Health News:Study: Want to be happier? Be more grateful 2Health News:Weight Watchers Members and Online Subscribers Lose an Estimated 4 Million Pounds in Six Week Period 2Health News:Weight Watchers Members and Online Subscribers Lose an Estimated 4 Million Pounds in Six Week Period 3Health News:Weight Watchers Members and Online Subscribers Lose an Estimated 4 Million Pounds in Six Week Period 4Health News:Physicists receive patent for improved cancer therapy device 2Health News:Physicists receive patent for improved cancer therapy device 3Health News:Renowned Thoracic Surgeon Recognized as 'Top Doctor' by Peers in Annual New Jersey Monthly Magazine Survey 2Health News:MINRAD International, Inc. Announces Termination of RxElite Holdings Inc. as Anesthetics Distributor for the Human Market in United States 2Health News:MINRAD International, Inc. Announces Termination of RxElite Holdings Inc. as Anesthetics Distributor for the Human Market in United States 3
(Date:11/9/2009)... , BETHESDA, Md., Nov. 9 /PRNewswire-Asia...aq: CHDX ), a leading independent American provid...the People,s Republic of China, today,announced re...cal 2010, which,ended September 30, 2009. , , ... quarter of fiscal 2010 was $38.1 million, flat on...
(Date:11/9/2009)... , BEND, Oregon, November 9 /PRNewswire/ ... years of experience in applying innovative pharma...most difficult scientific and,technical problems, ...ration,with Vertex Pharmaceuticals Incorporated, a...bridge, MA. , Through this new collaborat...
(Date:11/9/2009)... , SOUTH SAN FRANCISCO, Calif., Nov. 9 /PRNew... today announced that on November 5, 2009, it rece...asdaq") stating that the Nasdaq Hearing Panel has ... The NASDAQ Global Market subject to the condition...cember 31, 2009, the proposed merger (the "Merger"...
Breaking Medicine Technology:Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 2Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 3Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 4Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 5Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 6Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 7Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 8Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 9Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 10Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 11Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 2Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 3Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 2Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 3Hospital Infection Prevention Resources Cut Study Says 48288 1Hospital Infection Prevention Resources Cut Study Says 48288 2Hospital Infection Prevention Resources Cut Study Says 48288 3Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 48285 1Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 48285 2Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 48285 3Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 48285 4AssureRx Adds New CEO 12542 1AssureRx Adds New CEO 12542 2
...ntegrated Biomarker and Imaging Study) Results Dem...rug Development, SAN DIEGO, Calif., Sept. 2 Volc...403], a leading manufacturer of,intravascular ultr...nology,announced today the use of its VH(R) IVUS (...2 trial (Integrated Biomarker and Imaging Study). ...
...ermany, Sept. 2 Data presented today,at the Annua...howed that,the investigational oral Factor Xa inhi...mboembolism (VTE) compared with dalteparin among p...ment surgery. There was a,statistically significan...,observed bleeding rates were low across the group...
Other Medicine Technology:Volcano's VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKline's Novel Investigational Compound, Darapladib 2Volcano's VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKline's Novel Investigational Compound, Darapladib 3Volcano's VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKline's Novel Investigational Compound, Darapladib 4Daiichi Sankyo Announces Clinical Study Data for Oral Factor Xa Inhibitor DU-176b 2
Rectangular Square Presentation Case
Essilor Laboratories of America
Abba optical
Distribution Center
Medicine Products: